Similar articles

• Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) trial.

  Serebruany VL, Malinin AI, Pokov A, Barsness G, Hanley DF. Serebruany VL, et al. Am Heart J. 2008 Jan;155(1):93.e1-7. doi: 10.1016/j.ahj.2007.10.006. Epub 2007 Nov 26. Am Heart J. 2008. PMID: 18082496 Clinical Trial.
• Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.

  Duzenli MA, Ozdemir K, Aygul N, Soylu A, Tokac M. Duzenli MA, et al. Am J Cardiol. 2008 Aug 15;102(4):396-400. doi: 10.1016/j.amjcard.2008.03.074. Epub 2008 May 22. Am J Cardiol. 2008. PMID: 18678294 Clinical Trial.
• Dual antiplatelet drug resistance in patients with acute coronary syndrome.

  Guha S, Sardar P, Guha P, Roy S, Mookerjee S, Chakrabarti P, Deb PK, Chaudhuri U, Deb S, Karmakar R, Dasgupta AK, Lahiri P. Guha S, et al. Indian Heart J. 2009 Jan-Feb;61(1):68-73. Indian Heart J. 2009. PMID: 19729693
• Variability in responsiveness to oral antiplatelet therapy.

  Angiolillo DJ. Angiolillo DJ. Am J Cardiol. 2009 Feb 2;103(3 Suppl):27A-34A. doi: 10.1016/j.amjcard.2008.11.020. Am J Cardiol. 2009. PMID: 19166710 Review.
• Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy.

  Ben-Dor I, Kleiman NS, Lev E. Ben-Dor I, et al. Am J Cardiol. 2009 Jul 15;104(2):227-33. doi: 10.1016/j.amjcard.2009.03.022. Epub 2009 May 13. Am J Cardiol. 2009. PMID: 19576352 Review.